Europe’s medicine Agency EMEA has accepted Israel’s Prolor Biotech plan for a clinical trial of its long-acting human growth hormone (hGH-CTP) in children in Europe.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000656074&fid=1725
Israel to try to help Europe’s children grow
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.